FY16Q3 vs FY15Q3 comparison:
1. Revenue increase 10m, from FY15Q3 169m increase to FY16Q3 179m, +6%
2. Gross profit increase 1.5m, from FY15Q3 18m increase to FY16Q3 19.5m,+8.5%
3. PBT dropped 3.9m, from FY15Q3 17.3m reduced to FY16Q3 13.4m,- 23 %
4. Net profit dropped 2.8m, from FY15Q3 12.8m reduced to FY16Q3 10.0m, - 22%
5. EPS dropped 1.27cents, from FY15Q3 4.95cents reduced to 3.68cents, - 26%
2016 Quarterly vs 2015 Quarterly Financial Result Data
(a) Profit margin
Overall, profit margin increase constantly, from FY15 average 10.65% to FY16(Rolling 4Q) average 11.55%, an increasing about 0.90%, push up the gross profit
(b) Net profit
Net profit for FY15 is 39m, FY16(Rolling 4Q) 45m
FY15(YTDQ3)24.2m, FY16(YTDQ3)30.3m, let's assume FY16Q4 Luxchem will achieve > 10m, therefore net profit for FY16(40.3m) would be better than FY15(39.0m)
(c) EPS
EPS for FY15 is 14.94cents,FY16(Rolling 4Q) 16.82cents,at current share price RM1.67,P/E about 10
FY15(YTDQ3)9.30cents, FY16(YTDQ3) 11.09 cents,let's assume FY16Q4 Luxchem will achieve 4cents, therefore EPS for FY16(15.09cents) would be better than FY15(14.94cents)
Few main reason caused dropping in FY16Q3 net profit
(a) Dropping in other income/investment income - 5.1m
FY15Q3(YTD) , other income/investment income 8.07m reduced to FY16Q3(YTD) 2.96m。
Reason: most likely is opportunity cost from acquisition of Transfer Master 36.3m in cash consideration
(b) FOREX impact
During FY16Q1 , a realised FOREX LOSS 3.02m due to weaknesses of currency exchange rate USD to MYR. Annual report 2015, net currency exposure RM21.6m denominated by USD currency.
HUGE LOSS on FOREX in FY16Q1 3.02m affected net profit. Although FY16Q2 & FY16Q3 achieve reliased GAIN on FOREX 1.43m & 1.47m, but YTD16Q3 realised loss on FOREX 126k compare to FY15Q3(YTD) GAIN on FOREX 5.6m。
Reason: Company exposed to foreign currency risk, a 10% strengthening of USD will achieve 2.17m of net profit.
Based on historical average monthly exchange rate USD to MYR,a positive changes in current quarter VS previous quarter will beneficial Luxchem in realiased gain on FOREX, therefore increasing in net profit. FY16Q1 vs FY15Q4 negative 0.33(+0.23 to -0.10) causes realised FOREX LOSS 3.02m。
(c) ESOS expenses
An ESOS expenses about 800k incurred during FY16Q3, affected net profit 。FY15Q3 ESOS expenses is NIL. Too much exercise of ESOS not only will diluted the EPS, but also incurred huge expenses thay will affected net profit。
The management should put more effort to grab more business opportunity/cost saving that will bring positive future growth to Luxchem to minimize the dilution of EPS due to exercise of ESOS。
Fundamental Analysis of Luxchem - FY16Q3 Financial Result - Share price - 21/10/16 - RM1.67
1. ROIC - 0.41
2. EBIT multiple - 7.10 (average 6 years = 5.64)
3. CY - 8.19% (average 6 years = 7.65%)
Cash flow Analysis:
Although net profit dropped about 3.2m in FY16Q3 to 10.0m from 13.2m in FY16Q2, but cash flow of Luxchem still very strong.
Compare to FY15, inventories, trade receivables reduced, more cash in flow in CFFO.
While net repayment of trade payables & debts, reduce the interest expense in future, reduce the financial risk.
Cash equivalents for FY16Q3 at 97.8m, a decease about 3.18% compare to FY15 113.3m。 The main reason is due to payment in cash for acquisition of Transform Master 36.3m.
Other Analysis:
(1) Growth of EBIT VS CFFO - Positive growth
(2) Growth of CFFO VS Cash - Positive growth
(3) Growth of FCF vs Cash - Positive growth
(4) Cash/share vs FCF/share vs DPS - Dropped due to increasing of no. of share - bonus issue during 2014 & exercise of ESOS
Conclusion, bluefun still looking good on Luxchem future growth, beneficial from glove sector growth & weaknesses of MYR. Acquisition of Transform Master also will unlock the real value of its subsidiary. Patience waiting for Transform Master grows, maybe she will transform to a dragon in future, who knows?
Although the net profit dropped in FY16Q3, but well cash flow management by the company, still able to maintain as net cash company position, and turn the profit to cash in flow to its business operation.
Free cash flow=steady declaration in dividend as appreciation to shareholder.
Real growth = turn the profit to cash inflow(> CFFO, > FCF, > Cash)
Revenue is vanity, cash flow is sanity, but cash is king – Anonymous
bluefun
22.10.2016
P/S: This article is just for sharing purpose, this is not a buy call or sell call, any trade please on your own risks.
Original article link: http://bluefun168.blogspot.my/2016/10/luxchem5143.html
Please follow and support my FB page:
https://www.facebook.com/bluefun668
Chart | Stock Name | Last | Change | Volume |
---|
Another one of those kcchongnz disciples who only know how to key in the numbers without actually understanding the underlying meaning
2016-10-22 20:52
too bad the quarter result doesn't really explained why profit dropped. But as long as revenue trend is growing up, then this is positive sign. The rest depends on the management how to turn it to better profit. Overall, this year profit beyond previous profit is not a matter, quite similar with Top Glove performance.
2016-10-22 21:12
Hi Bluefun , thank you for your sharing and thumb up for your excellent and detailed analysis in Luxchem thus far. Please keep up the good work, just ignore those unconstructive comments. Time will tell who is right or wrong.
May I know how you calculate and obtain the figure of 45,747 in net CFFO and -8102 in net CFFI for 2016Q3? I just can’t get the value as you calculated, hope you can guide me on this, million thanks.
2016-10-22 21:17
Hi kenviscan, thanks for your good word & positive comment :)
The presentation of Luxchem Financial Results is a bit interesting if compare with other companies
CFFO = FY15(Annual report)- FY15Q3(Q report) + FY16Q3(Q report)
45,747 = 45,606 - 43,975 + 44,116
CFFI = FY15(Annual report)- FY15Q3(Q report) + FY16Q3(Q report)
-8,102 = - 3,051 - 213 + 591 + 200 - 5605 - 59 + 35
:)
2016-10-22 21:52
CFFI = purchase of PPE/IA + proceeds from disposal of PPE/IA
Hope will enlighten you :)
2016-10-22 21:54
Many thanks bluefun for the explanation and guidance on this. A lot of readers and true investors here had definitely benefited from your well written articles...Way to go, cheers...
2016-10-23 11:15
Earnings has started trending downward. It is almost certain that the next Qtr profit would be lower as comparing with last year due a reversal of ESOS RM 4.3 million in 4th Qtr 2015. Big boys may take advantage of the current weakness in earnings situation to press down the share price.
2016-10-23 18:03
This counter quite interesting. Looks like profit go down but recently they just acquired new subsidiary. It needs some time to merge with existing operations to grow up. It depends all on the management leadership and business strategy.
2016-10-23 18:28
Buy a high ROIC company, when low EBIT multiple with high EY
When the ship near the bridge,
the bridge will become straight
:)
2016-10-23 18:34
bluefun,
Well done in your analysis. A good analysis with facts and figures, rather than a sweeping statement.
Keep it up.
2016-10-23 18:43
Hi Mr KC,
Thanks for your positive comments. Thank you for sharing your Fundamental Analysis thought/idea. I have learn a lots of analysis skills from you.
You are my sifu forever
:)
2016-10-23 18:47
Wow, this is real good analyst for LUXCHEM .
I learn alot from here.
Tq ! bluefun .
2016-10-23 19:16
Bluefun, is the ship "become straight" la...:-) ha ha
Posted by bluefun > Oct 23, 2016 06:34 PM | Report Abuse
Buy a high ROIC company, when low EBIT multiple with high EY
When the ship near the bridge,
the bridge will become straight
:)
2016-10-23 21:00
Lol bro Yistock, i want to make something "unique" quote hahaha
I can't wait your new article that always enlighten me some "new idea/thought"
:D
2016-10-23 21:23
Hi bluefun, I cant get your figure. How do you derive EBIT? Besides, why need to deduct non-operating asset to derive enterprise value? Many thanks..
2016-10-25 09:13
Hi Patrick, sorry just noticed your comment.
EBIT rolling 4 Q = FY15 - FY15Q3 + FY16Q3
:)
2016-11-26 19:27
enning22
it is not a matter of good or bad , the issue is , whether it is over priced or not as currently traded in the market. so it is for now.
2016-10-22 18:22